Skye Bioscience, Inc. Common Stock Cash Flow Quality Index
Skye Bioscience, Inc. Common Stock cash flow quality index. Skye Bioscience, Inc. Common Stock (SKYE) has a Cash Flow Quality Index of 0.00x as of December 2025. Operating cash flow of $-9.77 Million is below net income of $11.08 Billion, suggesting accrual-heavy earnings not yet converted to cash. See SKYE financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Skye Bioscience, Inc. Common Stock (2012–2019)
Cash flow quality index of Skye Bioscience, Inc. Common Stock from 2012 to 2019. Historical Cash Flow Quality Index for Skye Bioscience, Inc. Common Stock across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore SKYE cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Skye Bioscience, Inc. Common Stock Cash Flow Quality Index by Year (2012–2019)
Skye Bioscience, Inc. Common Stock cash flow quality index by year from 2012 to 2019. Year-by-year earnings quality comparison for Skye Bioscience, Inc. Common Stock. For the full cash flow conversion analysis, see how efficiently does Skye Bioscience, Inc. Common Stock generate cash.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | -5.73x | $-6.03 Million | $1.05 Million | ▼ -1440.3% |
| 2012 | 0.43x | $1.93K | $4.51K | — |